Skip to main content
T&R Biofab Co., Ltd logo

T&R Biofab Co., Ltd — Investor Relations & Filings

Ticker · 246710 ISIN · KR7246710008 KO Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2022-05-09 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 246710

About T&R Biofab Co., Ltd

http://www.tnrbiofab.com/en/

T&R Biofab Co., Ltd. is a biomedical engineering company specializing in the development and commercialization of regenerative medical technologies. The company utilizes its proprietary 3D bioprinting technology to manufacture a range of products. Its primary offerings include 3D-printed, bioresorbable medical scaffolds designed to aid in the regeneration and reconstruction of tissues and organs. Other key business areas encompass bio-surgical solutions, the development of organoids and mini-tissues for research and therapeutic applications, and the use of human induced pluripotent stem cells (hiPSC).

Recent filings

Filing Released Lang Actions
[기재정정]분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '티앤알바이오팹' (T&R Biofab). It contains detailed financial statements, management discussion, and corporate information for the first quarter of 2021. Although it is labeled as a '정정신고' (Correction Report), it is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). Q1 2021
2022-05-09 Korean
[기재정정]반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Semi-Annual Report' (반기보고서) for the company 'T&R Biofab' (주식회사 티앤알바이오팹) for the period ending June 30, 2021. It contains detailed financial statements, management discussion, and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). Although it is labeled as a 'Correction Report' (정정신고), the core content is the full semi-annual financial report. H1 2021
2022-05-09 Korean
[기재정정]분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'T&R Biofab' (주식회사 티앤알바이오팹) for the 3rd quarter of the 9th fiscal year (2021.01.01-2021.09.30). It contains detailed financial statements, management discussion and analysis, and corporate governance information. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2021
2022-05-09 Korean
[기재정정]사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the company 'T&R Biofab' (주)티앤알바이오팹, which is the Korean equivalent of an Annual Report (10-K). It contains detailed financial statements, management discussion, governance information, and audit opinions for the fiscal year 2021. The document is a formal regulatory filing submitted to the Financial Services Commission and the Korea Exchange. Although it mentions a 'correction' (정정), the core content is the comprehensive annual financial and operational report. FY 2021
2022-05-09 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the acquisition and disposal of shares by KB Asset Management in the company TNR Biofab. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks changes in significant ownership levels.
2022-05-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by corporate insiders (directors, executives, and major shareholders) to disclose changes in their shareholdings. This falls under the 'Director's Dealing' category, which covers insider transactions and ownership reports.
2022-04-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.